American Journal of Clinical Oncology最新文献_第2页

Sentinel Node Navigation Surgery for Early Gastric Cancer: A Narrative Review. 早期胃癌的前哨节点导航手术：叙述性综述。

American Journal of Clinical Oncology Pub Date : 2024-04-08 DOI: 10.1097/coc.0000000000001101

Jiajie Zhou, Ruiqi Li, Shuai Zhao, Longhe Sun, Jie Wang, Yayan Fu, Daorong Wang

{"title":"Sentinel Node Navigation Surgery for Early Gastric Cancer: A Narrative Review.","authors":"Jiajie Zhou, Ruiqi Li, Shuai Zhao, Longhe Sun, Jie Wang, Yayan Fu, Daorong Wang","doi":"10.1097/coc.0000000000001101","DOIUrl":"https://doi.org/10.1097/coc.0000000000001101","url":null,"abstract":"Early gastric cancer (EGC) refers to malignant tumor lesions that are limited to the mucosa and submucosa layers, regardless of the presence of lymph node metastasis. Typically, EGC has a low rate of perigastric lymph node metastasis, and long-term survival outcomes are good after radical surgical treatment. The primary objective of surgical treatment for EGC is to achieve functional preservation while ensuring a radical cure. Sentinel node navigation surgery (SNNS) is a surgical technique used in the treatment of EGC. This approach achieves functional preservation by limiting lymph node dissection and performing restrictive gastrectomy guided by intraoperative negative sentinel node (SN) biopsy. Despite the apparent improvement in the detection rate of SN with the emergence of various tracing dyes and laparoscopic fluorescence systems, the oncological safety of SNNS remains a controversial research topic. SNNS, as a true form of stomach preservation surgery that enhances the quality of life, has become a topic of interest in the EGC field. In recent years, scholars from Japan and South Korea have conducted extensive research on the feasibility and safety of SNNS in the treatment of EGC. This article aims to provide reference choices for surgeons treating EGC by reviewing relevant research on SNNS for EGC in recent years.","PeriodicalId":501816,"journal":{"name":"American Journal of Clinical Oncology","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140586248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

First-line Immunotherapy for Metastatic Merkel Cell Carcinoma: Analysis of Real-world Survival Data and Practice Patterns. 转移性梅克尔细胞癌的一线免疫疗法：真实世界生存数据和实践模式分析。

American Journal of Clinical Oncology Pub Date : 2024-04-08 DOI: 10.1097/coc.0000000000001098

Hanna Kakish, James Sun, John B Ammori, Richard S Hoehn, Luke D Rothermel

引用次数: 0

Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysis. 转移性三阴性乳腺癌的三线治疗：系统综述与网络 Meta 分析》。

American Journal of Clinical Oncology Pub Date : 2023-12-15 DOI: 10.1097/coc.0000000000001073

Mingqiang Shi, Zhoujuan Li, Tianzhuo Wang, Miaozhou Wang, Zhen Liu, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao

引用次数: 0

Long-Term Outcomes after Abdominal Radiation for Wilms Tumor: A 20-Year Experience. Wilms 肿瘤腹部放疗后的长期疗效：20 年的经验

American Journal of Clinical Oncology Pub Date : 2023-12-13 DOI: 10.1097/coc.0000000000001074

Brianna Conte, Colette Shen, Patrick Thompson, Ian Davis, Dana L Casey

引用次数: 0